title: Conservative management complications after thrombolytic therapy.
authors.affiliation: Georgetown University Medical Center, Cardiac Catheterization Laboratory, Washington, DC.
authors.forename: E R
authors.initials: ER
authors.lastname: Mohler
authors.forename: K S
authors.initials: KS
authors.lastname: Stark
authors.forename: K M
authors.initials: KM
authors.lastname: Kent
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012008:Recurrence; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D011994:Recombinant Proteins; D006493:Heparin; D010959:Tissue Plasminogen Activator; D001241:Aspirin